Sellas Reports Promising AML Phase 2, Promising Ropeginterferon Boosts Blood Cancer Therapy, Cosmic Knots Reveal Matter Origins, Regeneron Drug Promises in MY Health, and more...
Update: 2025-12-08
Description
(0:10 ): SELLAS Life Sciences Reports Promising Phase 2 Results for AML Treatment at ASH 2025
(2:33 ): AOP Health Showcases Promising Ropeginterferon Results for Blood Cancer Treatment at ASH Meeting
(5:17 ): Japanese Physicists Propose Cosmic Knots Theory to Solve Matter Origin Mysteries
(7:39 ): Regeneron's Lynozyfic Shows Promise as Frontline Therapy for Multiple Myeloma in LINKER Trials
(10:11 ): Groundbreaking Study Maps Gut-Liver Pathway, Paving New Avenues for Diabetes and Obesity Treatment
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: SSBCrack News
(2:33 ): AOP Health Showcases Promising Ropeginterferon Results for Blood Cancer Treatment at ASH Meeting
(5:17 ): Japanese Physicists Propose Cosmic Knots Theory to Solve Matter Origin Mysteries
(7:39 ): Regeneron's Lynozyfic Shows Promise as Frontline Therapy for Multiple Myeloma in LINKER Trials
(10:11 ): Groundbreaking Study Maps Gut-Liver Pathway, Paving New Avenues for Diabetes and Obesity Treatment
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: SSBCrack News
Comments
In Channel






















